ABSTRACT
Introduction@#Intraocular lens (IOL) implants are monofocal and trifocal lenses which helps to clear up the vision after cataract surgery.@*Goal@#In this work, we aimed to compare the monofocal and trifocal IOL implantation during phacoemulsification surgery.@*Materials and Methods@#This study was conducted on 133 participants. Females comprised n=81, mean n=52 into equal groups. Preoperative and Postoperative cataract surgery UCVA and BCVA were measured and compared during the after 1 day, week 1, 2 weeks and month1. @*Statistical analysis@#The results of the study were processed using the SPSS 25.0 program after coding the data and checking for typographical errors. The normality of the data distribution was tested by inspecting a histogram. Categorical variables were compared using the chi-square test or Fisher's test. Statistical significance was determined at a p-value lower than 0.05@*Ethical statement@#The study was approved by the Research Ethics Committee of the Mongolian National University of Medical Sciences (No.2021/05/21). All patients provided written informed consent before participating in this study.@*Results@#The mean preoperative UCVA was 1.09±0.45D in monofocal IOL group, 0.99±0.49D in trifocal IOL group. At the first week: The mean postoperative UCVA at one week was 0.34±0.29D and 0.27±0.17D, in each group respectively. The mean postoperative BCVA in the first week was 0.28±0.27D and 0.20±0.15D in each group respectively. The mean postoperative UCVA at 1 month was 0.27±0.24D and 0.15±0.16D in each group, while BCVA was 0.26±24.94D and 0.06±0.63D.There was a highly significant statistical difference between the result of UCVA preoperative and the results of UCVA at the early and last postoperative follow up. @*Conclusion@#From our results, the best corrected visual acuity and was better for Trifocal group than Monofocal group. It is evident that post-operative near UCVA and BCVA was statistically significant at monofocal and trifocal groups.
ABSTRACT
Introducción. El cuestionario Convergence Insufficiency Symptoms Survey, (CISS-V15) es una herramienta para el diagnóstico y seguimiento del tratamiento de pacientes con insuficiencia de convergencia. Objetivo. Determinar la validez del cuestionario CISS-V15 para el diagnóstico de la insuficiencia de convergencia, frente a las pruebas clínicas con que se evalúa el estado motor ocular de los pacientes atendidos en consulta optométrica, en las ciudades de Recife y Salvador, Brasil. Métodos. Se llevó a cabo un estudio con enfoque cuantitativo, de tipo transversal y descriptivo, con 50 pacientes de dos instituciones educativas en Brasil. Se seleccionaron aquellos que cumplían con los criterios de inclusión para aplicar el cuestionario, y se identificaron los pacientes con insuficiencia de convergencia y aquellos con visión binocular normal. Se analizaron los resultados del cuestionario y las pruebas de motilidad ocular, para estimar medidas de tendencia central, y analizar los valores de sensibilidad y especificidad del cuestionario. Resultados. La prueba alcanzó una sensibilidad de 0,83 y una especificidad de 0,81. Conclusiones. Frente a las pruebas clínicas, el cuestionario CISS-V15 demostró tener validez diag-nóstica para las personas con insuficiencia de convergencia y aquellas con visión binocular normal, lo que lo convierte en una herramienta valiosa para el diagnóstico y seguimiento del tratamiento de los pacientes con insuficiencia de convergencia
Introduction: The Convergence Insufficiency Symptom Survey Questionnaire (CISS-V15) is a tool for diagnosis and monitoring of treatment of patients with convergence insufficiency. Objective: To determine the validity of the questionnaire CISS-V15 for the diagnosis of convergence insufficiency against clinical tests assessing the oculomotor state in optometric patients seen in con-sultation in the cities of Recife and Salvador, Brazil. Methods: A descriptive transversal study with a quantitative approach was conducted with 50 patients from two educational institutions in Brazil. Patients were selected from those that met the inclusion criteria for applying the questionnaire. Patients with convergence insufficiency and those with normal binocular vision were identified. The results of the questionnaire and ocular motility tests were analyzed to estimate central tendency measures and to analyze the sensitivity and specificity of the questionnaire. Results: The test had a sensitivity of 0.83 and a specificity of 0.81. Conclusions: Given the clinical test, the CISS-V15 questionnaire proved to be valid to classify individuals with convergence insufficiency, and those with normal binocular vision, which makes it a valuable tool for the diagnosis and monitoring of the treatment of patients with convergence insufficiency.
Subject(s)
Humans , Ocular Motility Disorders , Asthenopia , Diplopia , Reproducibility of Results , Vision, BinocularABSTRACT
We report a 47-year-old male who presented with acute monoocular vision loss, and had classical signs of global ocular ischemia in the right eye. Fundus fl uorescein angiography demonstrated delayed choroidal fi lling and no perfusion of retinal vasculature. Carotid Doppler and computed tomogram (CT) angiography studies revealed extensive bilateral atherosclerotic disease involving the carotid circulation. Ophthalmologists must be aware of the possibility of this potentially fatal condition, which is extremely rare. An astute clinical diagnosis, targeted workup for systemic associations and a prompt referral may turn out to be life-saving.
ABSTRACT
This paper reports a case of pegylated interferon-associated retinopathy in a patient with chronic hepatitis C. A 32-year-old female with chronic hepatitis C undergoing pegylated interferon and ribavirin combination therapy complained of visual blurring. Features of interferon-associated retinopathy, including ocular complications such as cotton wool spots, retinal hemorrhages, macular edema, and branch retinal vein occlusion, were found in the fundus of both of her eyes. Pegylated interferon combination therapy was stopped, and the retinopathy of the patient was treated with intravitreal bevacizumab injections and panretinal photocoagulations. This case shows that pharmacokinetically improved pegylated interferon has ocular complications for patients with chronic hepatitis C. Accordingly, patients undergoing pegylated interferon treatment for hepatitis C need regular eye examinations for protection of their vision.